Quality & complianceOfficial

Health Canada recalls Equate Ultra Strength Antacid lot over possible stainless steel fragments

🇨🇦 Health Canada · Fri 30 Oct 2026

A single lot of Equate Ultra Strength Antacid Assorted Fruits chewable tablets is recalled nationally in Canada after the possible presence of stainless steel shavings, classed Type II.

Health Canada has announced a recall of one lot of Equate Ultra Strength Antacid Assorted Fruits chewable tablets, saying the affected lot may contain foreign matter in the form of stainless steel shavings. The notice was published on 30 October 2026 under identification number RA-82891.

The product is a 1000 mg chewable tablet authorised under NPN 80125051. The affected lot is 1716089. The recall is classed as Type II and distribution was national. The depth of recall is at retail level.

Guardian Drug Company Inc., of Dayton, New Jersey, is listed as the company in the notice. The issue is categorised as a product quality problem within natural health products. The notice does not say how the metal came to be in the product, how many units are affected, or whether any adverse reactions have been reported.

Consumers are advised to check whether their product is affected and to consult a healthcare provider before stopping use or if they have health concerns. They can contact the recalling firm with questions about the recall, and report any side effects or other safety complaints to Health Canada.

For context, Health Canada uses Type II for recalls where use of the product may cause temporary or medically reversible adverse health effects, or where the likelihood of serious adverse effects is considered remote.

What it means for your team

  • Quality teams should note this as a foreign-matter case: metal fragments in a finished oral solid dose, confined to a single lot.
  • Companies handling Canadian natural health products should check their own lot traceability and retailer-level recall procedures against this example.
  • Pharmacovigilance teams may wish to watch for any complaints or adverse event reports linked to lot 1716089, as the notice gives no information on reported harm.

Official source: Health Canada ↗

Article written by VigiEye from the official source (Health Canada). AI-assisted; check the source before acting.

More Quality & compliance All →